Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. Essentially, persistent hepatitis B virus (HBV) infection is one of the most important risk factors for HCC1. Thus, targeted strategies to mitigate HBV ...
The global pandemic of type 2 diabetes (T2D) has increased noticeably over the last few dedicates with an estimated 463 million people affected globally since the 2019, which is projected to increased to 700 million by the year 2045 1 . Notably, T2D...
CME: 1 point
Deadline: 20 January 2025
Remark: You must complete both Part 1 and Part 2 in order to get CME 1 point
The World Health Organization (WHO) defines healthy ageing as the process of developing and maintaining the functional ability that enables wellbeing in older age.
CME: 1 point
Deadline: 20 January 2025
Remark: You must complete both Part 1 and Part 2 in order to get CME 1 point
The World Health Organization (WHO) defines healthy ageing as the process of developing and maintaining the functional ability that enables wellbeing in older age.
AQUIPTA® (Atogepant) ABBVIE HK Reg. No. HK-68287 (03 Jul, 2024) & HK-68288 (03 Jul, 2024) Composition: 1 Aquipta® (Atogepant) is an orally administered, small molecule, selective calcitonin gene-related peptide (CGRP) receptor antagonist...
ANAGRELIDE SANDOZ® (Anagrelide hydrochloride) NOVARTIS HK Reg. No. HK-68231 Composition: 2 ANAGRELIDE SANDOZ® (anagrelide hydrochloride) is an inhibitor of cyclic AMP phosphodiesterase III. It is available in 0.5 mg hard capsule. Indication:...
Multiple myeloma (MM) is a clonal plasma cell disorder characterised by excess production of monoclonal immunoglobulins and light chains that can ultimately lead to specific end-organ damage 1 . Notably, MM is the second most common haematologic mal...
Rabies is a zoonotic, and progressive neurological infection caused by Lyssavirus, affecting both animals and humans. Notably, more than 99% of human rabies are transmitted by unvaccinated dogs, and the disease affects more than 100 countries global...
TARGRETIN™ (bexarotene) MAIN LIFE HK Reg. No. HK-68294 (04 Jul, 2024) Composition: 1 Targretin™ (bexarotene) is a member of a subclass of retinoids that selectively activate retinoid X receptors (RXRs). Targretin™ is available in c...
LEQEMBI® (lecanemab) EISAI HK Reg. No. HK-68289 (03 Jul, 2024) & HK-68290 (03 Jul, 2024) Composition: 3 LEQEMBI® is an amyloid beta-directed antibody with the active ingredient lecanemab-irmb. It is administered as an intravenous infusio...
AKEEGA™ (niraparib and abiraterone acetate) JOHNSON & JOHNSON HK Reg. No. HK-68296 (09 Jul, 2024) & HK-68295 (09 Jul, 2024) Composition: 2 AKEEGA™ is a combination of niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, an...
